SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 455 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $67,925,748 | +7.1% | 560,351 | +1.1% | 0.02% | +5.6% |
| Q2 2023 | $63,448,890 | -11.5% | 554,042 | +6.6% | 0.02% | -18.2% |
| Q1 2023 | $71,666,639 | +7.1% | 519,964 | +0.7% | 0.02% | 0.0% |
| Q4 2022 | $66,922,758 | +22.4% | 516,459 | +4.4% | 0.02% | +10.0% |
| Q3 2022 | $54,678,000 | +49.6% | 494,640 | +1.4% | 0.02% | +53.8% |
| Q2 2022 | $36,555,000 | -2.4% | 487,654 | +1.7% | 0.01% | +18.2% |
| Q1 2022 | $37,442,000 | -11.2% | 479,285 | +2.4% | 0.01% | -8.3% |
| Q4 2021 | $42,169,000 | +8.9% | 468,279 | +11.9% | 0.01% | -7.7% |
| Q3 2021 | $38,718,000 | +23.3% | 418,659 | +3.7% | 0.01% | +30.0% |
| Q2 2021 | $31,391,000 | +6.8% | 403,793 | +2.4% | 0.01% | -9.1% |
| Q1 2021 | $29,398,000 | -55.8% | 394,432 | +1.0% | 0.01% | -57.7% |
| Q4 2020 | $66,568,000 | +23.3% | 390,449 | +1.6% | 0.03% | +4.0% |
| Q3 2020 | $53,994,000 | -6.5% | 384,487 | +6.7% | 0.02% | -10.7% |
| Q2 2020 | $57,752,000 | +74.7% | 360,179 | +6.6% | 0.03% | +47.4% |
| Q1 2020 | $33,064,000 | -22.5% | 338,001 | +2.2% | 0.02% | -17.4% |
| Q4 2019 | $42,686,000 | +74.4% | 330,791 | +1.8% | 0.02% | +64.3% |
| Q3 2019 | $24,478,000 | -47.4% | 324,984 | +6.1% | 0.01% | -50.0% |
| Q2 2019 | $46,559,000 | +38.8% | 306,409 | +8.9% | 0.03% | +33.3% |
| Q1 2019 | $33,550,000 | +17.2% | 281,477 | +7.3% | 0.02% | -4.5% |
| Q4 2018 | $28,635,000 | -25.6% | 262,386 | +10.1% | 0.02% | -15.4% |
| Q3 2018 | $38,480,000 | +27.5% | 238,246 | +4.3% | 0.03% | +18.2% |
| Q2 2018 | $30,181,000 | +27.1% | 228,331 | -28.7% | 0.02% | +22.2% |
| Q1 2018 | $23,743,000 | +47.5% | 320,456 | +10.8% | 0.02% | +38.5% |
| Q4 2017 | $16,100,000 | +32.2% | 289,349 | +7.7% | 0.01% | +18.2% |
| Q3 2017 | $12,182,000 | +67.9% | 268,553 | +24.8% | 0.01% | +57.1% |
| Q2 2017 | $7,255,000 | +19.4% | 215,190 | +4.9% | 0.01% | +16.7% |
| Q1 2017 | $6,074,000 | +14.1% | 205,187 | +5.7% | 0.01% | 0.0% |
| Q4 2016 | $5,325,000 | -48.6% | 194,108 | +15.1% | 0.01% | -50.0% |
| Q3 2016 | $10,360,000 | +253.1% | 168,691 | +9.7% | 0.01% | +200.0% |
| Q2 2016 | $2,934,000 | -0.5% | 153,816 | +1.8% | 0.00% | 0.0% |
| Q1 2016 | $2,949,000 | -48.3% | 151,050 | +2.1% | 0.00% | -50.0% |
| Q4 2015 | $5,708,000 | +37.1% | 147,945 | +14.1% | 0.01% | +33.3% |
| Q3 2015 | $4,163,000 | +8.7% | 129,622 | +3.0% | 0.01% | +20.0% |
| Q2 2015 | $3,830,000 | +161.4% | 125,848 | +14.1% | 0.01% | +150.0% |
| Q1 2015 | $1,465,000 | -17.3% | 110,312 | -9.8% | 0.00% | -33.3% |
| Q4 2014 | $1,771,000 | -23.3% | 122,337 | +11.9% | 0.00% | -25.0% |
| Q3 2014 | $2,308,000 | -27.7% | 109,375 | +2.1% | 0.00% | -20.0% |
| Q2 2014 | $3,191,000 | +36.1% | 107,112 | +9.8% | 0.01% | +25.0% |
| Q1 2014 | $2,345,000 | +28.3% | 97,552 | +8.7% | 0.00% | +33.3% |
| Q4 2013 | $1,828,000 | -51.1% | 89,728 | +14.0% | 0.00% | -62.5% |
| Q3 2013 | $3,740,000 | +33.5% | 78,686 | +8.4% | 0.01% | +33.3% |
| Q2 2013 | $2,801,000 | – | 72,597 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic Fund II, L.P. | 112,689 | $14,541,000 | 14.93% |
| Casdin Capital, LLC | 670,000 | $86,457,000 | 7.95% |
| Logos Global Management LP | 226,002 | $29,163,000 | 7.19% |
| Avoro Capital Advisors LLC | 1,760,000 | $227,110,000 | 6.67% |
| Camber Capital Management LP | 600,000 | $77,424,000 | 3.94% |
| STANSBERRY ASSET MANAGEMENT, LLC | 71,133 | $9,179,000 | 3.74% |
| Eventide Asset Management | 996,000 | $128,524,000 | 3.62% |
| CADIAN CAPITAL MANAGEMENT, LP | 550,000 | $70,972,000 | 3.14% |
| RTW INVESTMENTS, LP | 605,762 | $78,168,000 | 2.95% |
| Consonance Capital Management LP | 356,145 | $45,957,000 | 2.80% |